ALX Oncology Holdings Inc.
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2020 | $-9.0M | $-9.0M | $10.0K | $151.0K |
| Jun 2020 | $-6.2M | $-6.2M | $0 | $2.9M |
| Sep 2020 | $-9.5M | $-9.6M | $10.0K | $689.0K |
| Dec 2020 | $-13.6M | $-13.6M | $11.0K | $1.7M |
| Mar 2021 | $-5.1M | $-5.1M | $7.0K | $1.8M |
| Jun 2021 | $-20.6M | $-20.6M | $0 | $2.2M |
| Sep 2021 | $-24.9M | $-25.3M | $398.0K | $4.2M |
| Dec 2021 | $-17.5M | $-17.7M | $261.0K | $5.7M |
| Mar 2022 | $-20.7M | $-21.3M | $589.0K | $5.5M |
| Jun 2022 | $-17.0M | $-17.3M | $257.0K | $5.8M |
| Sep 2022 | $-30.9M | $-31.1M | $192.0K | $6.2M |
| Dec 2022 | $-20.7M | $-21.1M | $389.0K | $6.3M |
| Mar 2023 | $-27.8M | $-28.5M | $690.0K | $6.4M |
| Jun 2023 | $-31.7M | $-33.5M | $1.7M | $6.2M |
| Sep 2023 | $-31.2M | $-29.9M | $-1.3M | $7.0M |
| Dec 2023 | $-39.7M | $-39.8M | $148.0K | $6.7M |
| Mar 2024 | $-37.9M | $-38.1M | $148.0K | $7.0M |
| Jun 2024 | $-26.6M | $-26.7M | $90.0K | $7.3M |
| Sep 2024 | $-25.4M | $-25.5M | $149.0K | $7.0M |
| Dec 2024 | $-32.0M | $-32.1M | $60.0K | $5.9M |
| Mar 2025 | $-24.7M | $-24.7M | $60.0K | $5.2M |
| Jun 2025 | $-23.4M | $-23.5M | $47.0K | $2.1M |
| Sep 2025 | $-17.1M | $-17.1M | $56.0K | $2.5M |
| Dec 2025 | $-19.0M | $-19.0M | $49.0K | $2.7M |
| Mar 2026 | $-18.6M | $-18.7M | $50.0K | $2.5M |
| Jun 2026 | $-16.1M | $-16.1M | $17.0K | $2.7M |